Identification of Novel Molecular and Clinical Biomarkers of Survival in Glioblastoma Multiforme Patients: A Study Based on The Cancer Genome Atlas Data

Table 3

Means and medians for survival times, determined by the Kaplan-Meier method, for the two PRKCB methylation statuses. Survival is shown in days.

PRKCB methylation status	Mean				Median
	Estimate	SE	95% CI		Estimate	SE	95% CI
			Lower	Upper			Lower	Upper
Undermethylated	741.3	78.7	587	895.6	498	41.8	416.2	579.8
Methylated	501.7	56.5	390.9	612.6	419	24.7	370.6	467.4
Overall	611.6	48.3	516.8	706.4	438	25.1	388.7	487.3